synlab

SYNLAB's journey began in 1998 when Bartl Wimmer, along with partners, founded SYNLAB GmbH in Augsburg, Germany, as an association of freelance laboratory physicians. This marked the initial step towards creating a significant player in the European medical diagnostics landscape. A key development occurred in 2010 when SYNLAB merged with Futurelab and Fleming Labs, laying the groundwork for future expansion through acquisitions. The company's trajectory took a significant turn in 2015 when the European private equity investor Cinven acquired SYNLAB. This was followed by Cinven's acquisition of the French laboratory service provider Labco SA in August 2015. In October of the same year, Cinven took a majority stake in SYNLAB and merged the two entities, Labco and SYNLAB, to form the SYNLAB Group, headquartered in Munich, Germany. This merger established one of the largest European operators of medical diagnostic laboratories.

Under Cinven's ownership and the leadership of CEO Mathieu Floreani, who joined in 2018, SYNLAB has experienced substantial growth. The company has pursued a successful buy-and-build strategy, making numerous acquisitions across various countries. Between 2015 and 2022, SYNLAB completed 152 acquisitions in over 20 countries. This period also saw strategic investments in state-of-the-art laboratory and information technology to enhance efficiency and customer experience. SYNLAB has also focused on establishing strong partnerships with public hospitals and improving the accessibility of medical diagnostic services. The company went public in April 2021, listing on the Frankfurt Stock Exchange. Despite a challenging market environment, SYNLAB has demonstrated strong organic growth, driven by commercial and operational initiatives. Today, SYNLAB operates in over 30 countries across four continents, employing around 27,000 people and performing approximately 600 million laboratory tests annually. The company continues to be a leader in diagnostic services and specialty testing in Europe, offering a comprehensive range of over 5,000 routine and specialized tests.